Using a novel scoring system for paronychia related to oncologic treatments (SPOT) for assessing paronychia severity and its correlation with pain index and quality of life-Reference-Cited by-同舟云学术

Using a novel scoring system for paronychia related to oncologic treatments (SPOT) for assessing paronychia severity and its correlation with pain index and quality of life

Published:2018-07-06 Issue:1 Volume:33 Page:204-212
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Ho P.‐H.¹,Lin I.‐C.²,Yang X.³,Cho Y.‐T.¹,Chu C.‐Y.¹

Affiliation:

1. Department of Dermatology National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

2. Department of Dermatology National Cheng Kung University Hospital Tainan Taiwan

3. Department of Pharmacology Koo Foundation Sun Yat‐Sen Cancer Center Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

National Taiwan University

National Taiwan University Hospital

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15121

Reference40 articles.

1. Chemotherapy-associated paronychia treated with 2% povidone–iodine: a series of cases

2. Nail changes secondary to docetaxel chemotherapy : a case report

3. Taxane-induced nail changes: incidence, clinical presentationand outcome

4. Nail toxicities induced by systemic anticancer treatments

5. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the combination of cryotherapy and topical timolol solution superior to cryotherapy alone in the treatment of epidermal growth factor receptor inhibitor-induced paronychia? A double-blinded, left-to-right comparison, randomized controlled trial;Journal of the American Academy of Dermatology;2023-11

2. The impact of comorbidities, neutrophil-to-lymphocyte ratio, and drug toxicities on quality of life in lung cancer patients receiving EGFR-TKI therapy;Journal of the Formosan Medical Association;2023-08

3. NECOM Skincare Algorithm for Patients With Cancer and Survivors;J DRUGS DERMATOL;2023

4. The Impact of Comorbidities, Neutrophil-to-lymphocyte Ratio, and Adverse Events on Quality of Life in Lung Cancer Patients Receiving EGFR-TKI Therapy;2022-09-28

5. Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan;Journal of Oncology Pharmacy Practice;2022-09-15